Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Complex Medical Dermatology: Clinicopathologic Correlation
Description
In a recent clinicopathologic discussion, a dermatologist presented case studies focusing on complex medical dermatology, particularly mucocutaneous eruptions. The first case highlighted a 32-year-old woman with a painful desquamative rash that evolved over a week, leading to severe symptoms including fever and conjunctival injection. Clinical examination revealed erosive plaques and significant laboratory findings indicated leukopenia, anemia, and acute kidney injury. A punch biopsy showed signs consistent with connective tissue disease, ultimately diagnosing her with acute cutaneous lupus. Treatment involved high-dose IV steroids, and the patient responded well despite some residual skin disease. The second case involved a 57-year-old man undergoing treatment for colorectal cancer, who developed a progression of a rash and oral mucositis following chemotherapy. He presented with notable erythema and mucositis, and a biopsy indicated toxic erythema due to chemotherapy. Notably, the use of high-dose vitamin D was discussed as a therapeutic approach, showing promise in reducing inflammation associated with chemotherapy. The dermatologist emphasized clinical pearls for care, including recognizing the adverse effects of treatment methods and the importance of preventive strategies during chemotherapy.
View moreConclusions
- The presentation discusses the complex nature of mucocutaneous eruptions, particularly focusing on cases of acute cutaneous lupus and toxic erythema of chemotherapy.
- A 32-year-old female presented with a painful desquamative rash, ultimately diagnosed as acute cutaneous lupus, which exhibited a high in-hospital survival rate compared to other conditions like Stevens-Johnson syndrome (SJS).
- Detailed clinical and histopathological evaluations are critical for distinguishing between various bullous and desquamative skin conditions.
- Skin biopsies reveal crucial insights into underlying causes, distinguishing between connective tissue diseases and drug-induced reactions.
- High-dose vitamin D is suggested to mitigate skin inflammation associated with toxic erythema of chemotherapy.
- Preventative measures are essential to avoid exacerbation of skin conditions in patients undergoing chemotherapy.
- Acute lupus serologies, direct immunofluorescence, and clinical findings are vital for accurate diagnoses amidst overlapping symptoms.
- PMID: 35139156 Toxic epidermal necrolysis as a manifestation of acute cutaneous lupus erythematosus
- PMID: 23761100 A case of toxic epidermal necrolysis-like skin lesions with systemic lupus erythematosus and review of the literature
- PMID: 30142736 Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: report of a case and review of the literature
- PMID: 34046141 Bullous lesions in patients with cutaneous lupus erythematosus: A clinicopathologic study
- PMID: 27245834 Clinical and Histopathologic Spectrum of Toxic Erythema of Chemotherapy: A Series of 56 Cases From a Single Institution
- PMID: 34401432 Toxic epidermal necrolysis-like toxic erythema of chemotherapy: 2 illustrative cases
- PMID: 35262213 Enfortumab Vedotin-Associated Toxic Epidermal Necrolysis-like Toxic Erythema of Chemotherapy
- PMID: 36542397 High-Dose Vitamin D for the Management of Toxic Erythema of Chemotherapy in Hospitalized Patients
- PMID: 37583837 High-dose vitamin D for the management of acute radiation dermatitis.